Page last updated: 2024-09-02

1-(carboxymethylthio)tetradecane and HIV Infections

1-(carboxymethylthio)tetradecane has been researched along with HIV Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aukrust, P; Berge, RK; Bohov, P; Dyrøy, E; Fredriksen, J; Frøland, SS; Halvorsen, B; Melby, K; Melbye, L; Skalhegg, BS; Skorve, J; Ueland, T1

Other Studies

1 other study(ies) available for 1-(carboxymethylthio)tetradecane and HIV Infections

ArticleYear
Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy.
    European journal of clinical investigation, 2004, Volume: 34, Issue:10

    Topics: Adult; Animals; Anti-Inflammatory Agents; Female; HIV Infections; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Leukocytes, Mononuclear; Lipids; Male; Mice; Middle Aged; Pilot Projects; Receptors, Immunologic; Receptors, Scavenger; Reverse Transcriptase Polymerase Chain Reaction; Sulfides; Up-Regulation

2004